EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Engineered Biomolecular Condensates Limit Tobacco Mosaic Virus Accumulation and Symptom Development

Alyssa M Stanfield iD, Jared P May iD

Molecular Plant Pathology · 2025

DOI: 10.1111/mpp.70113 ↗

At a glance

Journal article in Molecular Plant Pathology, 2025. Written by Alyssa M Stanfield and 1 co-authors. Institution: Division of Biological & Biomedical Systems, School of Science and Engineering, University of Missouri-Kansas City, Kansas City, Missouri, USA. Major MEDLINE topics: Tobacco Mosaic Virus, Biomolecular Condensates, Plant Diseases. Cited 4 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIGMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Artificial condensates formed by liquid–liquid phase separation (LLPS) have been extensively studied in the field of synthetic biology for their ability to control cellular functions in a reversible and tunable manner. Although cellular condensates can restrict viral accumulation, the potential to employ LLPS as a platform for targeted antiviral strategies remains understudied. Here, we engineered tobacco mosaic virus (TMV) to harbour MS2 bacteriophage hairpins that are specifically bound by the MS2 coat protein (MCP). Using well‐studied intrinsically disordered regions (IDRs) as scaffolds, we engineered artificial condensates that could target MS2‐tagged TMV, inhibiting TMV accumulation up to fivefold following transient expression in Nicotiana benthamiana . TAR DNA‐binding protein 43 (TDP‐43)‐based condensates inhibited MS2‐tagged virus accumulation by over twofold, independent of the global translational repression observed during condensate expression. Following manual inoculation of MS2‐tagged TMV onto leaves transiently expressing TDP‐43:MCP condensates, systemic virus accumulation was reduced by over 10‐fold, which was associated with a significant decrease in symptom severity. These results provide a foundation for developing artificial biomolecular condensates to mitigate plant virus accumulation and disease severity.

Subjects

MeSH terms (MEDLINE)

Tobacco Mosaic VirusBiomolecular CondensatesPlant DiseasesNicotianaCapsid ProteinsLevivirusDNA-Binding ProteinsPlant Leaves

Author keywords

LLPSRNA virusartificial condensatebiomolecular condensateliquid–liquid phase separationplant virus

Substances

Capsid ProteinsDNA-Binding Proteins

Authors and institutions

  • Division of Biological & Biomedical Systems, School of Science and Engineering, University of Missouri-Kansas City, Kansas City, Missouri, USA.

ORCID profiles: Alyssa M Stanfield, Jared P May

Funding

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Cite

APA

Stanfield, A. M., & May, J. P. (2025). Engineered Biomolecular Condensates Limit Tobacco Mosaic Virus Accumulation and Symptom Development. Molecular Plant Pathology. https://doi.org/10.1111/mpp.70113

Vancouver

Stanfield AM, May JP. Engineered Biomolecular Condensates Limit Tobacco Mosaic Virus Accumulation and Symptom Development. Molecular Plant Pathology. 2025. doi:10.1111/mpp.70113

BibTeX
@article{Stanfield2025,
  author = {Stanfield, Alyssa M and May, Jared P},
  title = {Engineered Biomolecular Condensates Limit Tobacco Mosaic Virus Accumulation and Symptom Development},
  journal = {Molecular Plant Pathology},
  year = {2025},
  doi = {10.1111/mpp.70113}
}
Start for free →